Skip to content

Effect of a topical gel containing Sumac extract and Cloxacillin on diabetic foot ulcer

Investigating the effect of a topical gel containing Sumac extract and Cloxacillin on diabetic foot ulcer: a double-blind placebo-controlled trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220310054247N1
Enrollment
66
Registered
2022-06-06
Start date
2022-06-05
Completion date
Unknown
Last updated
2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Diabetic foot ulcer caused by type 1 diabetes. Condition 2: Diabetic foot ulcer caused by type 2 diabetes. Type 1 diabetes mellitus with diabetic peripheral angiopathy without gangrene Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene

Interventions

Intervention 1: Intervention group: Both groups (intervention and control) receive routine treatment including debridement, infection control and treatment (if the wound becomes infected), hospitaliza

Sponsors

Karaj University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with type 1 or 2 Diabetes Age 30 years or older Grade 1 and 2 diabetic ulcers according to Wagner classification system Adherence to routine diabetes treatments Ankle Brachial Index (ABI) greater than 0.7

Exclusion criteria

Exclusion criteria: Pregnancy or Breastfeeding Presence of infection in the wound before admission Presence of neoplasia Use of immunosuppressive drugs

Design outcomes

Primary

MeasureTime frame
Wound area and dimensions. Timepoint: Weekly for 8 weeks. Method of measurement: Photography of ulcers and Computer software.;Presence or absence of infection in the wound. Timepoint: Weekly for 8 weeks. Method of measurement: Wound examination and Visual observation.

Secondary

MeasureTime frame
Incidence of side effects. Timepoint: Evaluation will be weekly from the first week to the eighth week. Method of measurement: Asking the patient and Examining the wound by the visitor (symptoms such as burning, itching, redness, etc. while using the gel).;Tolerability. Timepoint: Evaluation will be weekly from the first week to the eighth week. Method of measurement: Ask the patient if there is any discomfort while taking the drug or If there is any factor that makes the patient reluctant to continue treatment and the cause is related to the gel used.;Pain assessment. Timepoint: Before the intervention and the end of the eighth week. Method of measurement: The patient scores from one to ten, depending on the amount of pain he feels.(Visual Analogue Scale).;Quality of life score. Timepoint: Before the intervention and the end of the eighth week. Method of measurement: Questionnaire for quality of life of patients with diabetic foot ulcers.(Designed by Johnson in the UK, 1995).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Mahdi Ahmadian-Attari

Karaj University of Medical Sciences

ahmadian.attari@gmail.com+98 26 3256 7175

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026